{"version":"1.0","type":"link","title":"Efficacy and Safety of Aumolertinib/Icotinib Combination Therapy for Naive EGFR-Mutant NSCLC Patients with Brain Metastases: A Phase I/II Study.","author_name":"Yu M 외","author_url":"https://prs-insight.online/author/Yu%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/96941","thumbnail_width":1200,"thumbnail_height":630}